About Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome is a rare disease catalogued by Orphanet (ORPHA:86818). It is associated with the KCNE5, ACSL4, AMMECR1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome trials.
Search ClinicalTrials.gov for "Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome" or filter by Orphanet code ORPHA:86818 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome. Updated daily.